These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2639761)

  • 1. Studies on the nature of physiologically processed antigen and on the conformation of peptides required for interaction with MHC.
    Grey HM; Demotz S; Buus S; Sette A
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():393-9. PubMed ID: 2639761
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemistry of peptide interactions with MHC proteins.
    Sette A; Grey HM
    Curr Opin Immunol; 1992 Feb; 4(1):79-86. PubMed ID: 1596372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing.
    Viner NJ; Nelson CA; Deck B; Unanue ER
    J Immunol; 1996 Apr; 156(7):2365-8. PubMed ID: 8786292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural intermediates in the reactions of antigenic peptides with MHC molecules.
    Dornmair K; Rothenhäusler B; McConnell HM
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():409-16. PubMed ID: 2639762
    [No Abstract]   [Full Text] [Related]  

  • 5. Binding of immunogenic peptides to Ia histocompatibility molecules. 1985.
    Babbitt BP; Allen PM; Matsueda G; Haber E; Unanue ER
    J Immunol; 2005 Oct; 175(7):4163-5. PubMed ID: 16177052
    [No Abstract]   [Full Text] [Related]  

  • 6. Appreciating the complexity of MHC class II peptide binding: lysozyme peptide and I-Ak.
    Nelson CA; Viner NJ; Unanue ER
    Immunol Rev; 1996 Jun; 151():81-105. PubMed ID: 8872486
    [No Abstract]   [Full Text] [Related]  

  • 7. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
    Sanderson S; Frauwirth K; Shastri N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7217-21. PubMed ID: 7638170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: a single MHC anchor residue alters the conformation of a peptide-MHC complex inducing T cells that survive negative selection.
    Peterson DA; DiPaolo RJ; Kanagawa O; Unanue ER
    J Immunol; 2001 May; 166(10):5874-7. PubMed ID: 11342600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naturally-occurring peptide antigens derived from the MHC class-I-restricted processing pathway.
    Rötzschke O; Falk K
    Immunol Today; 1991 Dec; 12(12):447-55. PubMed ID: 1723878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of peptide antigen presentation by a second peptide.
    de Kroon AI; McConnell HM
    Proc Natl Acad Sci U S A; 1993 Oct; 90(19):8797-801. PubMed ID: 8105466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the interaction of peptide hen egg white lysozyme (34-45) with the I-Ak molecule.
    Lambert LE; Unanue ER
    J Immunol; 1989 Aug; 143(3):802-7. PubMed ID: 2787347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phagosomes are fully competent antigen-processing organelles that mediate the formation of peptide:class II MHC complexes.
    Ramachandra L; Song R; Harding CV
    J Immunol; 1999 Mar; 162(6):3263-72. PubMed ID: 10092778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of both MHC class I- and class II-restricted antigenic peptides from exogenously added ovalbumin in murine phagosomes.
    Muno D; Kominami E; Mizuochi T
    FEBS Lett; 2000 Jul; 478(1-2):178-82. PubMed ID: 10922492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal trimming of peptides for presentation on major histocompatibility complex class II molecules.
    Nelson CA; Vidavsky I; Viner NJ; Gross ML; Unanue ER
    Proc Natl Acad Sci U S A; 1997 Jan; 94(2):628-33. PubMed ID: 9012835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting peptide binding to Major Histocompatibility Complex molecules.
    Liao WW; Arthur JW
    Autoimmun Rev; 2011 Jun; 10(8):469-73. PubMed ID: 21333759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic peptide binding by class I and class II histocompatibility proteins.
    Stern LJ; Wiley DC
    Structure; 1994 Apr; 2(4):245-51. PubMed ID: 8087551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of conformational propensity of peptide antigens in their interaction with MHC class II molecules. Failure to document the importance of regular secondary structures.
    Sette A; Lamont A; Buus S; Colon SM; Miles C; Grey HM
    J Immunol; 1989 Aug; 143(4):1268-73. PubMed ID: 2787362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of class II MHC-peptide complex formation by protease inhibitors.
    Liang MN; Witt SN; McConnell HM
    J Immunol Methods; 1994 Jul; 173(1):127-31. PubMed ID: 8034980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms and consequences of peptide selection by the I-Ak class II molecule.
    Latek RR; Unanue ER
    Immunol Rev; 1999 Dec; 172():209-28. PubMed ID: 10631948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of truncated peptides to the MHC molecule IA (d).
    Dornmair K; Clark BR; McConnell HM
    FEBS Lett; 1991 Dec; 294(3):244-6. PubMed ID: 1661686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.